Amedisys Inc (AMED)
96.63
-0.53
(-0.55%)
USD |
NASDAQ |
Sep 27, 16:00
96.56
-0.07
(-0.07%)
After-Hours: 20:00
Amedisys SG&A Expense (Annual): 780.06M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 780.06M |
| December 31, 2022 | 754.06M |
| December 31, 2021 | 711.24M |
| December 31, 2020 | 668.30M |
| December 31, 2019 | 607.93M |
| December 31, 2018 | 501.31M |
| December 31, 2017 | 482.21M |
| December 31, 2016 | 503.43M |
| December 31, 2015 | 452.44M |
| December 31, 2014 | 441.74M |
| December 31, 2013 | 474.07M |
| December 31, 2012 | 516.67M |
| December 31, 2011 | 506.81M |
| December 31, 2010 | 543.30M |
| December 31, 2009 | 509.76M |
| December 31, 2008 | 423.28M |
| Date | Value |
|---|---|
| December 31, 2007 | 246.64M |
| December 31, 2006 | 229.93M |
| December 31, 2005 | 168.42M |
| December 31, 2004 | 97.63M |
| December 31, 2003 | 69.58M |
| December 31, 2002 | 63.06M |
| December 31, 2001 | 53.66M |
| December 31, 2000 | 49.25M |
| December 31, 1999 | 53.15M |
| December 31, 1998 | 33.51M |
| December 31, 1997 | 24.44M |
| December 31, 1996 | 18.51M |
| December 31, 1995 | 13.80M |
| December 31, 1994 | 8.50M |
| December 31, 1993 | 4.70M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
607.93M
Minimum
2019
780.06M
Maximum
2023
704.32M
Average
711.24M
Median
2021
SG&A Expense (Annual) Benchmarks
| Regional Health Properties Inc | 3.976M |
| Addus HomeCare Corp | 234.79M |
| OptimizeRx Corp | 58.02M |
| Health Catalyst Inc | 143.88M |
| Option Care Health Inc | 607.43M |